Keeping it real: The importance of material characterization in nanotoxicology

Biochemical and Biophysical Research Communications

Volumn 468, Issue 3, 2015, Pages 498-503

  Fadeel, Bengt ^a   Fornara, Andrea ^b   Toprak, Muhammet S ^c   Bhattacharya, Kunal ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SP TECHNICAL RESEARCH INSTITUTE OF SWEDEN   (Sweden)

^c ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Bio corona; Engineered nanomaterials; Nanotoxicology; Physicochemical characterization

Indexed keywords

MULTI WALLED NANOTUBE; NANOMATERIAL; NANOPARTICLE;

CELL FUNCTION; CELL VIABILITY; CYTOKINE PRODUCTION; DOSIMETRY; HIGH THROUGHPUT SCREENING; HUMAN; MEDICAL DECISION MAKING; NANOTECHNOLOGY; NANOTOXICOLOGY; OCCUPATIONAL SAFETY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RADIATION DOSE; REVIEW; SURFACE AREA; SURFACE PROPERTY; BIOASSAY; MATERIALS TESTING; PROCEDURES; TOXICITY TESTING;

BIOLOGICAL ASSAY; MATERIALS TESTING; NANOPARTICLES; TOXICITY TESTS;

EID: 84951568750     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.06.178     Document Type: Review

References (48)

1. H.F. Krug Nanosafety research-are we on the right track? Angew. Chem. Int. Ed. Engl. 53 2014 12304 12319
2. F. Schrurs, and D. Lison Focusing the research efforts Nat. Nanotechnol. 7 2012 546 548
3. G. Oberdörster, E. Oberdörster, and J. Oberdörster Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles Environ. Health Perspect. 113 2005 823 839
4. B. Fadeel Nanosafety: towards safer design of nanomedicines J. Intern. Med. 274 2013 578 580
5. G. Oberdörster, A. Maynard, K. Donaldson, V. Castranova, J. Fitzpatrick, K. Ausman, J. Carter, B. Karn, W. Kreyling, D. Lai, S. Olin, N. Monteiro-Riviere, D. Warheit, and H. Yang Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy Part Fibre Toxicol. 2 2005 8
6. D.B. Warheit How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol. Sci. 101 2008 183 185
7. C.M. Sayes, and D.B. Warheit Characterization of nanomaterials for toxicity assessment Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1 2009 660 670
8. Editorial Join the dialogue Nat. Nanotechnol. 7 2012 545
9. B. Fadeel, and K. Savolainen Broaden the discussion Nat. Nanotechnol. 8 2013 71
10. B. Fubini, M. Ghiazza, and I. Fenoglio Physico-chemical features of engineered nanoparticles relevant to their toxicity Nanotoxicology 4 2010 347 363
11. J. Lead, and S. Holgate Regulatory and research needs Nat. Nanotechnol. 8 2013 72
12. D.R. Boverhof, and R.M. David Nanomaterial characterization: considerations and needs for hazard assessment and safety evaluation Anal. Bioanal. Chem. 396 2010 953 961
13. K.A. Dawson Leave the policing to others Nat. Nanotechnol. 8 2013 73
14. H. Bouwmeester, I. Lynch, H.J. Marvin, K.A. Dawson, M. Berges, D. Braguer, H.J. Byrne, A. Casey, G. Chambers, M.J. Clift, G. Elia, T.F. Fernandes, L.B. Fjellsbø, P. Hatto, L. Juillerat, C. Klein, W.G. Kreyling, C. Nickel, M. Riediker, and V. Stone Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices Nanotoxicology 5 2011 1 11
15. K.A. Dawson, S. Anguissola, and I. Lynch The need for in situ characterisation in nanosafety assessment: funded transnational access via the QNano research infrastructure Nanotoxicology 7 2013 346 349
16. E.A. Bleeker, W.H. de Jong, R.E. Geertsma, M. Groenewold, E.H. Heugens, M. Koers-Jacquemijns, D. van de Meent, J.R. Popma, A.G. Rietveld, S.W. Wijnhoven, F.R. Cassee, and A.G. Oomen Considerations on the EU definition of a nanomaterial: science to support policy making Regul. Toxicol. Pharmacol. 65 2013 119 125
17. V. Stone, S. Pozzi-Mucelli, L. Tran, K. Aschberger, S. Sabella, U. Vogel, C. Poland, D. Balharry, T. Fernandes, S. Gottardo, S. Hankin, M.G. Hartl, N. Hartmann, D. Hristozov, K. Hund-Rinke, H. Johnston, A. Marcomini, O. Panzer, D. Roncato, A.T. Saber, H. Wallin, and J.J. Scott-Fordsmand ITS-NANO-prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy Part Fibre Toxicol. 11 2014 9
18. L. Farcal, F.T. Andón, L. Di Cristo, B.M. Rotoli, O. Bussolati, E. Bergamaschi, A. Mech, N.B. Hartmann, K. Rasmussen, J. Riego-Sintes, J. Ponti, A. Kinsner-Ovaskainen, F. Rossi, A. Oomen, P. Bos, R. Chen, R. Bai, C. Chen, L. Rocks, N. Fulton, B. Ross, G. Hutchison, L. Tran, S. Mues, R. Ossig, J. Schnekenburger, L. Campagnolo, L. Vecchione, A. Pietroiusti, and B. Fadeel Comprehensive in vitro toxicity testing of a panel of representative oxide nanomaterials: first steps towards an intelligent testing strategy PLoS One 10 2015 e0127174
19. T. Xia, R.F. Hamilton, J.C. Bonner, E.D. Crandall, A. Elder, F. Fazlollahi, T.A. Girtsman, K. Kim, S. Mitra, S.A. Ntim, G. Orr, M. Tagmount, A.J. Taylor, D. Telesca, A. Tolic, C.D. Vulpe, A.J. Walker, X. Wang, F.A. Witzmann, N. Wu, Y. Xie, J.I. Zink, A. Nel, and A. Holian Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: the NIEHS nano GO consortium Environ. Health Perspect. 121 2013 683 690
20. A. Kroll, C. Dierker, C. Rommel, D. Hahn, W. Wohlleben, C. Schulze-Isfort, C. Göbbert, M. Voetz, F. Hardinghaus, and J. Schnekenburger Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays Part Fibre Toxicol. 8 2011 9
21. J.B. Hall, M.A. Dobrovolskaia, A.K. Patri, and S.E. McNeil Characterization of nanoparticles for therapeutics Nanomedicine (Lond.) 2 2007 789 803
22. P.P. Adiseshaiah, J.B. Hall, and S.E. McNeil Nanomaterial standards for efficacy and toxicity assessment Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2 2010 99 112
23. M. Hull, A.J. Kennedy, C. Detzel, P. Vikesland, and M.A. Chappell Moving beyond mass: the unmet need to consider dose metrics in environmental nanotoxicology studies Environ. Sci. Technol. 46 2012 10881 10882
24. D. Lison, G. Vietti, and S. van den Brule Paracelsus in nanotoxicology Part Fibre Toxicol. 11 2014 35
25. P.M. Hinderliter, K.R. Minard, G. Orr, W.B. Chrisler, B.D. Thrall, J.G. Pounds, and J.G. Teeguarden ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies Part Fibre Toxicol. 7 2010 36
26. J.M. Cohen, J.G. Teeguarden, and P. Demokritou An integrated approach for the in vitro dosimetry of engineered nanomaterials Part Fibre Toxicol. 11 2014 20
27. A.K. Pal, D. Bello, J. Cohen, and P. Demokritou Implications of in vitro dosimetry on toxicological ranking of low aspect ratio engineered nanomaterials Nanotoxicology 12 2015 1 15 ([Epub ahead of print])
28. A.K. Pal, I. Aalaei, S. Gadde, P. Gaines, D. Schmidt, P. Demokritou, and D. Bello High resolution characterization of engineered nanomaterial dispersions in complex media using tunable resistive pulse sensing technology ACS Nano 8 2014 9003 9015
29. B. Fadeel, N. Feliu, C. Vogt, A.M. Abdelmonem, and W.J. Parak Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 5 2013 111 129
30. A.E. Nel, L. Mädler, D. Velegol, T. Xia, E.M. Hoek, P. Somasundaran, F. Klaessig, V. Castranova, and M. Thompson Understanding biophysicochemical interactions at the nano-bio interface Nat. Mater. 8 2009 543 557
31. M.P. Monopoli, C. Åberg, A. Salvati, and K.A. Dawson Biomolecular coronas provide the biological identity of nanosized materials Nat. Nanotechnol. 7 2012 779 786
32. I. Lynch, A. Ahluwalia, D. Boraschi, H.J. Byrne, B. Fadeel, P. Gehr, A.C. Gutleb, M. Kendall, and M.G. Papadopoulos The bio-nano-interface in predicting nanoparticle fate and behaviour in living organisms: towards grouping and categorising nanomaterials and ensuring nanosafety by design BioNanoMaterials 14 2013 195 216
33. A. Pietroiusti, L. Campagnolo, and B. Fadeel Interactions of engineered nanoparticles with organs protected by internal biological barriers Small 9 2013 1557 1572
34. S. Tenzer, D. Docter, J. Kuharev, A. Musyanovych, V. Fetz, R. Hecht, F. Schlenk, D. Fischer, K. Kiouptsi, C. Reinhardt, K. Landfester, H. Schild, M. Maskos, S.K. Knauer, and R.H. Stauber Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology Nat. Nanotechnol. 8 2013 772 781
35. C.D. Walkey, and W.C. Chan Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment Chem. Soc. Rev. 41 2012 2780 2799
36. C.D. Walkey, J.B. Olsen, F. Song, R. Liu, H. Guo, D.W. Olsen, Y. Cohen, A. Emili, and W.C. Chan Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles ACS Nano 8 2014 2439 2455
37. R. Liu, W. Jiang, C.D. Walkey, W.C. Chan, and Y. Cohen Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties Nanoscale 7 2015 9664 9675
38. S. Ritz, S. Schöttler, N. Kotman, G. Baier, A. Musyanovych, J. Kuharev, K. Landfester, H. Schild, O. Jahn, S. Tenzer, and V. Mailänder Protein corona of nanoparticles: distinct proteins regulate the cellular uptake Biomacromolecules 16 2015 1311 1321
39. J.H. Arts, M. Hadi, A.M. Keene, R. Kreiling, D. Lyon, M. Maier, K. Michel, T. Petry, U.G. Sauer, D. Warheit, K. Wiench, and R. Landsiedel A critical appraisal of existing concepts for the grouping of nanomaterials Regul. Toxicol. Pharmacol. 70 2014 492 506
40. J.H. Arts, M. Hadi, M.A. Irfan, A.M. Keene, R. Kreiling, D. Lyon, M. Maier, K. Michel, T. Petry, U.G. Sauer, D. Warheit, K. Wiench, W. Wohlleben, and R. Landsiedel A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) Regul. Toxicol. Pharmacol. 71 Suppl. 2 2015 S1 S27
41. H. Godwin, C. Nameth, D. Avery, L.L. Bergeson, D. Bernard, E. Beryt, W. Boyes, S. Brown, A.J. Clippinger, Y. Cohen, M. Doa, C.O. Hendren, P. Holden, K. Houck, A.B. Kane, F. Klaessig, T. Kodas, R. Landsiedel, I. Lynch, T. Malloy, M.B. Miller, J. Muller, G. Oberdorster, E.J. Petersen, R.C. Pleus, P. Sayre, V. Stone, K.M. Sullivan, J. Tentschert, P. Wallis, and A.E. Nel Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making ACS Nano 9 2015 3409 3417
42. A. Nel, T. Xia, H. Meng, X. Wang, S. Lin, Z. Ji, and H. Zhang Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening Acc. Chem. Res. 46 2013 607 621
43. F. Meng, and V.M. Ugaz Instantaneous physico-chemical analysis of suspension-based nanomaterials Sci. Rep. 5 2015 9896
44. D.G. Thomas, S. Gaheen, S.L. Harper, M. Fritts, F. Klaessig, E. Hahn-Dantona, D. Paik, S. Pan, G.A. Stafford, E.T. Freund, J.D. Klemm, and N.A. Baker ISA-TAB-Nano: a specification for sharing nanomaterial research data in spreadsheet-based format BMC Biotechnol. 13 2013 2
45. J. Hastings, N. Jeliazkova, G. Owen, G. Tsiliki, C.R. Munteanu, C. Steinbeck, and E. Willighagen eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessment J. Biomed. Semant. 6 2015 10
46. D.J. Gentleman, and W.C. Chan A systematic nomenclature for codifying engineered nanostructures Small 5 2009 426 431
47. D.A. Tomalia In quest of a systematic framework for unifying and defining nanoscience J. Nanopart. Res. 11 2009 1251 1310
48. E.K. Richman, and J.E. Hutchison The nanomaterial characterization bottleneck ACS Nano 3 2009 2441 2446